BioSpecifics Technologies (BSTC) Stock Research, Analysis & News

Quick Analysis on BioSpecifics Technologies (BSTC) Stock as of October 17, 2017

Previous Closing Price $46.92 is below its 50 day moving average $47.14
Previous Closing Price $46.92 is below its 200 day moving average $50.03
The Price/Earnings To Growth ratio (PEG) is great than 1
The Stock pays no dividend
The closing price $46.92 is more than 53.45% away from its one year target price of $72.00
Current Short Ratio 4.98 is great than 1
Average trading volume is relatively low at 24,023
It is a very small cap stock with market cap of $334.85M
(See more information about BioSpecifics Technologies (BSTC) Stock below)

BioSpecifics Technologies (BSTC) Stock Profile Summary

Biospecifics Technologies Corp., a biopharmaceutical company, involves in the development of an injectable collagenase for various indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. for injectable collagenase for clinical indications in Dupuytrens contracture, Peyronies disease, and frozen shoulder. BioSpecifics Technologies also focuses on the development of collagenase for various other clinical indications, including lipomas and cellulite. The company was founded in 1957 and is headquartered in Lynbrook, New York.

BioSpecifics Technologies (BSTC) Stock Key Statistics Research and Analysis as of October 17, 2017

Stock ExchangeNGM
Market Capitalization$334.85M
Trade Volume (Average Trading Volume)19,051 (24,023)
Current Year EPS Estimate$1.59
Next Year EPS Estimate$1.69
Previous Closing Price$46.92
50 Day Price Moving Average$47.14
200 Day Price Moving Average$50.03
1 yr Target Price$72.00
PEG Ratio1.36
Short Ratio4.98

BioSpecifics Technologies (BSTC) Stock Competitor Research and Analysis

Pfizer Inc. (PFE)Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)Mylan, Inc. (MYL)
Johnson & Johnson (JNJ)GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)Novartis AG (NVS)
AstraZeneca PLC (AZN)Abbott Laboratories (ABT)

Stock Research on BioSpecifics Technologies (BSTC)

Latest Market News on BioSpecifics Technologies (BSTC)

Click here to find the latest news on BioSpecifics Technologies (BSTC)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Pfizer Inc. (PFE)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)
AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)